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ABSTRACT : After a brain injury, raised tempera-
ture may be due to a regulated readjustment in the
hypothalamic ‘set-point’ in response to inflamma-
tion. The purpose of this report is to mention possi-
ble implications related to temperature and homeo-
stasis of morphine treatment in a patient with brain
injury.
During the month previous to her hospitalization
in our city she was treated for fever with paracetamol
and metamizol without results. After 31 days with
similar results, we changed to morphine IV consider-
ing the possibility of treating pain and fever. This
option was successful and afterwards we changed to
fentanyl patches, keeping fever absent. After 100 days
of hospitalization, the patient was discharged to her
home.
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INTRODUCTION
Several areas of the hypothalamus, including the para-
ventricular hypothalamus, the ventromedial hypothala-
mus, the posterior hypothalamus and the dorsomedial
hypothalamus have been implicated in thermogenesis. It
has been also stated that maintenance of central tempera-
ture is determined by the balance between heat production
and heat loss. Interesting studies on central drug effects
and its different responses related to temperature and
homeostasis have focused on opioids, which are known to
inhibit the release of different neurotransmitters in the
central nervous system and alter normal cerebral meta-
bolism.
Raised temperature may be due to a regulated readjust-
ment in the hypothalamic ‘set-point’ in response to inflam-
mation and infection, or it may occur as a consequence of
damage to the hypothalamus and/or its pathways. The
mitochondrial respiratory chain-linked oxidative phospho-
rylation and calcium transport are compromised by trau-
matic brain injury (TBI) and support the idea that oxidative
stress and perturbation of cellular calcium homeostasis
play significant roles in TBI [1].
Fever in patients with severe head injury is a common-
ly-encountered diagnostic and management problem.
Neurogenic fever is a noninfectious source of fever in the
patient with head injury and, if untreated, can cause dam-
age to the brain in many ways. Until recently, neurogenic
fever was thought to be a relatively rare consequence of
TBI, but other studies have reported that 4 to 37% of TBI
survivors experience this sequela. Neurogenic fever is
essentially a diagnosis of exclusion [2]. It is only when
sepsis is excluded that neurogenic fever can be considered.
Though brain temperature is indeed higher than the core
temperature in the acute phase of severe TBI, that signi-
ficance is uncertain with regard to outcome prediction,
since there has been a paucity of work on the use of direct
methods of brain temperature monitoring [3].
Hemodynamic data has shown that morphine increases
intracranial pressure and decreases mean arterial blood
pressure and cerebral perfusion pressure in patients with
severe brain injury. Also, several changes observed in rats
after morphine microinjection into the anterior hypothala-
mus showed a clear etiology of hypothermia as a central
response to morphine. The purpose of this report is to
mention possible implications related to temperature and
homeostasis of morphine treatment in a patient with brain
injury. 
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RÉSUMÉ : Après une lésion cérébrale, la tempéra-
ture élevée peut être due à un réajustement régulé
par l’hypothalamus en réponse à l’inflammation. Le
but de ce rapport est de mentionner les implications
possibles liées à la température et à l’homéostase du
traitement morphinique chez une patiente ayant une
lésion cérébrale. 
Au cours du mois précédant son hospitalisation
dans notre ville, la fièvre avait été traitée avec paracé-
tamol et métamisol, sans résultats. Après 31 jours de
résultats similaires, nous avons opté pour la morphine
IV envisageant la possibilité de traiter conjointement
la douleur et la fièvre. Cette option a été un succès, et
par la suite nous avons utilisé les patchs de fentanyl
pour éliminer les accès de fièvre. La patiente a pu
regagner son domicile après cent jours d’hospitalisa-
tion.
Mots-clés : fièvre centrale, lésion cérébrale, morphine
CASE REPORT
A 23-year-old woman, who was victim of a car accident,
was admitted to our institution on June 15, 2009. Due to
the TBI (Figure 1), she had undergone decompressive
craniectomy and subdural catheter placement for monitor-
ing intracranial pressure. During one month she was treat-
ed in an Intensive Care Unit with esomeprazole, ferrous
sulfate, metoclopramide, mannitol, sedation, relaxation,
enteral diet based on alitraq, carbamazepine, tetrazepam,
valproic acid, mechanical ventilatory support and finally
gastrostomy. 
On the physical examination she arrived to our hospital
with persistent fever, weighing 40 kg, with a 7 (4-1-2)
Glasgow Coma Score (GCS), spontaneous eyelid open-
ing, arreflectic right mydriasis, left eye with pupil diame-
ter of 3 mm and papillary atrophy, meningeal signs were
absent. She did not follow simple commands and after a
painful stimulus she assumed decerebration position.
There were no dysautonomias in addition to fever.
Clinical data
Electroencephalogram (Figure 2) on two occasions
showed severe brain damage with slow waves. To exclude
fever by infection, several studies were performed (axial
computerized tomography of all the body, blood smear,
chest X-ray, cerebrospinal fluid analysis, febrile reactions
[Weil-Felix and Widal tests], hematic biometry, hemocul-
ture, influenza A and B test, interleukin 1-ß, urine culture,
etc.), all being normal. A tracheal aspiration culture was
positive for Pseudomona aeruginosa and was treated
against this pathogen until being negative. 
Treatment
Hemotransfusions were realized as required whenever
euthermia occurred. Electrolyte disturbances were cor-
rected and urinary flows closely watched. During the
month previous to her hospitalization in our city she was
treated for fever with paracetamol and metamizol without
results.
After 31 days with similar clinical evolution, we
changed to morphine IV, 0.05 mg/kg/h, considering the
possibility of treating pain and fever. This option was suc-
cessful with fever remission the following day (Figure 3).
Afterwards, there was only one fever spike on day 33 with
morphine and from day 34 we observed an absolute re-
mission that allowed us to switch to fentanyl patches,
keeping fever absent. After 100 days of hospitalization,
she was discharged to her home with a 7 (4-1-2) GCS.
DISCUSSION
Even moderate temperature elevation soon after acute
cerebral damage may markedly worsen initial brain in-
jury. This effect may justify aggressive antipyretic treat-
ment. An attempt to correct fever appears warranted in all
patients with acute cerebral damage in order to obtain a
better functional recovery and to limit maximally any fur-
ther insult to the brain [4].
In the brain, energy metabolism is mainly oxidative.
The oxidative metabolism and heat production are, there-
fore, strongly related. After major cerebral injuries, such
as subarachnoid haemorrhage or traumatic brain injury,
cerebral temperature can often exceed systemic tempera-
ture. Mitochondrial dysfunction is probably the corner
stone of these post-injury perturbations of brain tempera-
ture. Understanding this phenomenon remains, however,
not complete [5]. It is hoped that earlier diagnosis and
appropriate intervention for central fever will lead to
improved outcomes [6].
It has long been recognized that opioids such as mor-
phine can produce a range of effects on body temperature
in a number of species including man [7-13], but only few
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FIGURE 1. Magnetic resonance imaging showing sagittal (a) and 
axial (b) slices of the brain.
a
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studies have analyzed the impact of this drug in central
fever. Evidence has shown that hypothermia is certainly
due to a central action of morphine since it occurs when
morphine is applied by microinjection into the anterior
hypothalamus. Within the last few years, a number of
studies have been conducted to investigate whether mor-
phine plays a role in temperature regulation, fever, and
hypothermia [11,14]. Collected data has suggested that,
according to the opioid/morphine receptor subtype that is
stimulated, changes in temperature can be observed [12,
15]. Mu agonists have been an important component of
pain treatment for thousands of years. The usual pharma-
cokinetic parameters (half-life, clearance, volume of dis-
tribution) of opioids have been known for some time.
However, the metabolism has, until recently, been poor-
ly understood, and there has been recent interest in the
role of metabolites in modifying the pharmacodynamic
response in patients, in both analgesia and adverse effects.
A number of opioids are available for clinical use, includ-
ing morphine, hydromorphone, levorphanol, oxycodone,
and fentanyl [16].
In experimental studies, morphine pharmacokinetics is
different in the brain compared with other tissues due to
the properties of the blood-brain barrier and the action of
efflux pumps. It has been reported in humans that the
basal state in which morphine is administered to patients
may either obey an active efflux of morphine metabolism
in a healthy brain tissue or on the other hand, follow an
increase in permeability in damaged parenchyma. A re-
cent explanation for this statement is based on the P-glyco-
protein membrane protein which transports substrates
across cerebral endothelial cells back to the blood stream
and its permeability capacity to upstream morphine ab-
sorption in focal mass lesions and brain swelling. 
Some studies have evaluated a down-regulation effect of
Mu opioid receptors secondary to desensitization of Mu-
Opioid-Receptor (MOR)-mediated G-protein activity due
to levels of tolerance and relation to central nervous system
mediated effects of morphine exposure. In an experimental
study, MOR blockade resulted in inhibition of adenylyl
cyclase activity and calcium channels and activation of
potassium channels and several intracellular kinases. The
final observed effect was the production of hypothermia.
Other authors have suggested that nitric oxide (NO) has an
antipyretic function, and that several neuronal and periph-
eral NO isoforms may interact with morphine doses, either
to block or allow temperature changes.
Neuroinflammation hypotheses also have proposed
that tendency of lowering central and peripheral body
temperature after morphine administration can be linked
to an immune system response suppressing natural killer
cell activity, antibody responses, spleen and peripheral
FIGURE 2.  Electroencephalogram showing severe cortical brain damage.
FIGURE 3. Thermic curves from day 25 to 32 of hospitalization. Day 32 was the beginning of I.V. morphine infusion.
(Thermic curves of more days are available if requested to the corresponding author.) 
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blood cell responses to mitogens and macrophage func-
tion leading to a decrease of the inflammatory stimuli
mainly within the preoptic anterior hypothalamus.
Available data indicate that ambient temperature, dose,
specific opioid used and central or peripheral activity of
receptors may greatly affect thermoregulatory responses
to opioids. Tolerance is one of the undesired potential
secondary effects of morphine administration and it has
been suggested in experimental protocols that chronic
exposure leads to a down-regulation of mu-opioid recep-
tor mRNA in peripheral sensory ganglia supporting this
fact.
Our patient had a chronic deficit in either sensing tem-
perature elevations or activating heat dissipation mecha-
nisms under thermal stress as was reported in another
case [17].
Evidence obtained in clinical and experimental studies
has demonstrated the importance and metabolic differ-
ences observed on a healthy brain exposed to morphine
compared to a damaged tissue; this may lead to paradoxi-
cal changes related to morphine pharmakocinetics and
potential intra- and extracranial effects. In rats, subcuta-
neous injection of morphine produces either a fall or a rise
in body temperature according to dosage; future clinical
evidence based on ethical support may lead to concrete
explanation of this statement in humans.
Strong evidence related to temperature changes after
morphine administration in humans with brain injury is
limited, but the distinct roles of Mu and K receptor types
may be important in understanding the mechanisms of
opioid-induced effects on body temperature, and these
receptors may also play specific roles in thermoregulation.
As mentioned above, suggested links between the opioid
and immune systems may lead to a better understanding
of temperature regulation pathogenesis and fu-ture thera-
peutic approaches. 
In summary, The pathophysiology and management of
neurogenic fever is not well understood and needs more
research and understanding for better management and a
favorable outcome. We propose morphine as an anti-
pyretic option in a context that justifies its other systemic
and multiple effects as an advantage for patients with
brain injury or trauma with no response to hyperthermia
standardized treatment, and after excluding potential fever
causes. Possible adverse effects of this treatment include
behavioral and neuro-adaptive effects of morphine, like
neural plasticity, dependence, withdrawal and antinoci-
ception, probably caused as a consequence of glutamater-
gic influence. 
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